Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Juno ROCKETs On Fast Clinical Hold Resolution

Executive Summary

The FDA lifted a clinical hold on the Phase II ROCKET clinical trial for Juno's lead CAR-T therapy candidate JCAR015 less than a week after it was instituted, allowing the company to proceed without using fludarabine in a pre-conditioning chemotherapy regimen.

Advertisement

Related Content

Juno Stresses Differences Between Its CAR-Ts As JCAR015 Trial Put On Hold Again
Synthetic Biology And The Computerization Of Drug Development
New Interim CAR-T Data Support Kite’s BLA Submission Plans
INTERVIEW: Juno CEO Hans Bishop On The CAR-T Learning Curve
Juno, Kite Stand By Their Products As Novartis's Shift Renews CAR-T Concerns
CAR-T Update: Kite's Filing Coming Soon
Don't Panic! Novartis Is Still Invested In CAR-T Despite 2Q Silence
Does Novartis Need A Big Immuno-Oncology Deal? Jimenez Says No
Uncertainty Looms For Ziopharm After Patient Death

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC096877

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel